SAN FRANCISCO–Tempo Bioscience, Inc. (“Tempo”), a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived cell products and affiliated cell-based services in the following categories: [Read more…]
Stem Cell News
BioInformant's coverage of stem cell news includes iPS cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells and more.
As the first and only market research firm to specialize in stem cell news, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine.
Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry news.
GOOD Meat, the World’s First-to-Market Cultivated Meat Company, Receives U.S. FDA Clearance
Acclaimed chef José Andrés will be first in the country to serve GOOD Meat’s chicken
ALAMEDA, Calif.–GOOD Meat, the cultivated meat division of food technology company Eat Just, Inc., announced today that it has received a “no questions” letter from the U.S. Food and Drug Administration as part of one of the agency’s first pre-market consultations for a new kind of meat, poultry and seafood made from cells instead of raised and slaughtered animals. The letter means that following a careful and rigorous evaluation, the FDA has accepted the company’s conclusion that its first poultry product, cultivated chicken, is safe to eat. [Read more…]
$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy
Collaboration with La Trobe University, The University of Queensland, Australian National University, Cytiva and SeerPharma Pty Ltd
19 January 2023, Melbourne, Australia – VivaZome Therapeutics Pty Ltd (“VivaZome”) is delighted to announce that it has been awarded an Australian Government Round 13 CRC-P grant of $3.0m in support of the project “Customised exosomes – the future of regenerative medicine”. [Read more…]
Ronawk Brings On Dr. David S. Zamierowski As New Member of the Board of Directors
March 10, 2023, Olathe, KS – Ronawk, a biotech and biofabrication company powered by the Bio-Block UniverseTM, is pleased to announce the appointment of Dr. David S. Zamierowski to its Board of Directors. Dr. Zamierowski has a storied career as both a Plastic Surgeon and Inventor. He has developed countless advancements in many areas of life science. [Read more…]
Center for Breakthrough Medicines, Nucleus Biologics, and Stoic Bio Announce Strategic Collaboration for Steady Supply of Quality Controlled Cell Culture Media to Expedite Development of Cell and Gene Therapies
March 7, 2023, SAN DIEGO, CA — In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, have announced plans for a supply agreement with the Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization (CDMO), whose mission is to save lives by accelerating the development and manufacture of advanced therapies. This agreement makes Nucleus Biologics the preferred supplier of cell culture media and other critical biological solutions for CBM; thus, ensuring a steady, consistent supply of this critical material with tighter quality control measures. [Read more…]
- « Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 145
- Next Page »